Neuren Pharmaceuticals Limited NURPF
14.00 USD -0.28 (-1.94%)
At closeNov 3, 2026, 4:00 PM EST
14.00 Day range 14.00
7.70 52-week range 17.25
- YTD
- +8.44%
- 1 year
- +4.87%
- Market cap
- 1.77B
- EPS (ttm)
- 0.10
- P/E ratio
- 140.00
- YTD return
- +8.44%
- 1-year return
- +4.87%
- Volume
- 6.22K
- Avg volume
- 590
- Open
- 14.00
- Previous close
- 14.28
- Day's range
- 14.00 – 14.00
- 52-week range
- 7.70 – 17.25
- Earnings date
- Aug 25, 2026
6M +5.18 (+58.73%)
Next earnings
Aug 25, 2026
Expected Aug 25, 2026. Consensus EPS estimate 0.06831.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 25, 2026 | Jun 30, 2026 | 0.06831 | — | — | — |
| Feb 25, 2026 | Dec 31, 2025 | 0.00901 | 0.079 | +0.07 | +776.80% |
| Aug 26, 2025 | Jun 30, 2025 | 0.07661 | 0.07635 | 0.00 | -0.34% |
| Feb 27, 2025 | Dec 31, 2024 | 0.641 | 0.635 | -0.01 | -0.94% |
| Aug 26, 2024 | Jun 30, 2024 | 0.07299 | 0.04086 | -0.03 | -44.02% |
| Feb 28, 2024 | Dec 31, 2023 | 0.669 | 0.568 | -0.10 | -15.10% |
News
Neuren Pharmaceuticals Limited (NURPF) Q2 2026 Earnings Call Transcript 
Hyperion DeFi (NASDAQ:HYPD) versus Neuren Pharmaceuticals (OTCMKTS:NURPF) Critical Survey 
Neuren Pharmaceuticals (OTCMKTS:NURPF) Stock Price Down 13.5% – Should You Sell? 
Neuren Pharmaceuticals Limited (NURPF) Discusses Share Buyback Program, Financial Position, and Development Strategy for NNZ-2591 Transcript 
Stocks That Hit 52-Week Highs On Friday 
Stocks That Hit 52-Week Highs On Friday
Your note
Sign in to keep a note on NURPF — it syncs with the Stock Master app.